147 related articles for article (PubMed ID: 10772093)
1. The frequency of mutation in CCR5 gene among Koreans.
Oh MD; Kim SS; Kim EY; Lee S; Kim N; Park KY; Kim U; Kim T; Kim T; Choe K; Lee JS
Int J STD AIDS; 2000 Apr; 11(4):266-7. PubMed ID: 10772093
[TBL] [Abstract][Full Text] [Related]
2. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
Teixeira SL; Bastos FI; Hacker MA; Morgado MG
Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection.
Romiti ML; Colognesi C; Cancrini C; Mas A; Berrino M; Salvatori F; Orlandi P; Jansson M; Palomba E; Plebani A; Bertran JM; Hernandez M; de Martino M; Amoroso A; Tovo PA; Rossi P; Espanol T; Scarlatti G
Mol Med; 2000 Jan; 6(1):28-36. PubMed ID: 10803406
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
5. Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders.
Lu Y; Nerurkar VR; Dashwood WM; Woodward CL; Ablan S; Shikuma CM; Grandinetti A; Chang H; Nguyen HT; Wu Z; Yamamura Y; Boto WO; Merriwether A; Kurata T; Detels R; Yanagihara R
Int J Infect Dis; 1999; 3(4):186-91. PubMed ID: 10575146
[TBL] [Abstract][Full Text] [Related]
6. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
[TBL] [Abstract][Full Text] [Related]
8. [Identification of new mutant sites and 894C deletion variant genotyping of HIV-1 coreceptor CCR5 in indigenous Chinese populations].
Liu M; Wang F; Hong W; Wang B; Jin L; Lei Z; Hou J
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1468-72. PubMed ID: 12509908
[TBL] [Abstract][Full Text] [Related]
9. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
Takácová M; Nogová P; Hábeková M; Staneková D
Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
[TBL] [Abstract][Full Text] [Related]
11. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).
Rugeles MT; Solano F; Díaz FJ; Bedoya VI; Patiño PJ
J Clin Virol; 2002 Jan; 23(3):161-9. PubMed ID: 11595595
[TBL] [Abstract][Full Text] [Related]
13. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.
Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM
J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918
[TBL] [Abstract][Full Text] [Related]
14. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
Walli R; Reinhart B; Luckow B; Lederer E; Loch O; Malo A; Wank R; Schlöndorff D; Goebel FD
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):229-33. PubMed ID: 9665499
[TBL] [Abstract][Full Text] [Related]
15. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
[TBL] [Abstract][Full Text] [Related]
16. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
Gastroenterology; 2002 Jun; 122(7):1721-8. PubMed ID: 12055576
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].
Deng XL; Hong KX; Chen JP; Ruan YH; Xu MY; Qin GM; Li K; Xing H; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1050-3. PubMed ID: 15769362
[TBL] [Abstract][Full Text] [Related]
18. Detection of new mutant sites of HIV-1 coreceptor CCR5 among Saudi populations.
Abuelsaad AS; Al-Ghamdi AS; Al-Ghamdi AN; Alakkas EA; Alsulaimani AA; Al-Harthi AA; Abdel-Moneim AS
J Interferon Cytokine Res; 2013 Dec; 33(12):783-9. PubMed ID: 23742258
[TBL] [Abstract][Full Text] [Related]
19. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals.
Mazzucchelli R; Corvasce S; Violin M; Riva C; Bianchi R; Dehò L; Velleca R; Cibella J; Bada M; Moroni M; Galli M; Balotta C
J Biol Regul Homeost Agents; 2001; 15(3):265-71. PubMed ID: 11693435
[TBL] [Abstract][Full Text] [Related]
20. The effects of RANTES/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected Koreans.
Jang DH; Choi BS; Kim SS
Int J Immunogenet; 2008 Apr; 35(2):101-5. PubMed ID: 18218038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
